Introduction
============

Ossification of the ligamentum flavum (OLF) of the spine is characterized by ectopic bone formation in the ligament flavum and is highly prevalent in the population of East Asia, including the Japanese and Chinese populations ([@b1-ijmm-39-01-0135]--[@b4-ijmm-39-01-0135]). Epidemiological studies have demonstrated that OLF frequently occurs in the thoracic spine. Thoracic OLF (TOLF) progresses insidiously over a long period of time, resulting in devastating spinal cord injury that invariably leads to serious myelopathy. Many factors contribute to OLF, including genetic background, dietary habits, metabolic abnormalities and mechanical stress ([@b5-ijmm-39-01-0135]--[@b7-ijmm-39-01-0135]).

TOLF most often affects one or two levels of the spine and presents mainly in the lower thoracic spine (T10-T12) ([@b8-ijmm-39-01-0135]), which is a mobile transition region that may be more prone to degeneration owing to the high tensile forces in the posterior column. Axial mechanical overload and the consequent increase in repetitive tensile strain on ligamentum tissues contribute to TOLF ([@b9-ijmm-39-01-0135]). Additionally, we have previously found that mechanical stress induces the osteogenic differentiation of cells from patients with TOLF ([@b6-ijmm-39-01-0135],[@b10-ijmm-39-01-0135]). Thus, local abnormal mechanical stress is thought to contribute to the progression of TOLF. However, there are also many cases of multiple-level TOLF in immobile, as well as mobile segments that differ from single-level lesions in terms of disease progression and clinical outcomes ([@b11-ijmm-39-01-0135]--[@b13-ijmm-39-01-0135]). On the basis of the whole clinical condition, we hypothesized that TOLF involving multiple levels extensively and TOLF in the circumscribed region may have a different pathogenesis. Probably on the account of the differences in genetic background, the osteogenic differentiation potency may be intrinsically greater in multiple-level TOLF than in single-level TOLF.

During osteogenic differentiation, transcription factors, such as osterix and Runt-related transcription factor-2 (Runx2) and osteogenesis-related genes, such as bone morphogenetic protein (BMP)2 regulate the expression of osteoblast markers, including alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCN) among others ([@b7-ijmm-39-01-0135],[@b14-ijmm-39-01-0135]--[@b16-ijmm-39-01-0135]). Susceptibility genes, including collagen type VI alpha1 (COL6A1), BMP4 and major histocompatibility complex, class II, DQ alpha1 (HLA-DQA1) have also been shown to be associated with the occurrence of TOLF ([@b17-ijmm-39-01-0135],[@b18-ijmm-39-01-0135]).

To date, single- and multiple-level TOLF have not been investigated as separate conditions and there have been no comparative studies examining differences in osteogenic differentiation potency and related gene expression, at least to the best of our knowledge. Only a similar and preliminary research was conducted on the ossification of the posterior longitudinal ligament (OPLL) ([@b19-ijmm-39-01-0135]). Thus, this was addressed in the present study using spinal ligament samples obtained from patients with single- and multiple-level TOLF in which osteogenic differentiation was induced by the application of cyclic mechanical stress.

Materials and methods
=====================

Clinical diagnosis and spinal ligament samples
----------------------------------------------

The diagnosis of TOLF or non-TOLF (i.e., other thoracic diseases) was confirmed by pre-operative radiography, computed tomography and magnetic resonance imaging (MRI) of the whole spine. We previously established a TOLF classification scheme based on lesion distribution in MRI ([@b20-ijmm-39-01-0135]), as follows ([Fig. 1](#f1-ijmm-39-01-0135){ref-type="fig"}): circumscribed (ossification in 2 or fewer adjacent levels), continuous (continuous ossification in 3 or more levels) and intermittent (intermittent distribution of local or continuous ossification). To assess genetic differences in the osteogenic differentiation potency among lesion types, a comparative analysis of single- and multiple-level TOLF (1 and ≥5 levels, respectively) was performed. Non-TOLF specimens were obtained from patients with other thoracic spine diseases, such as trauma or disc herniation, who had no ossification in any spinal ligaments. Spinal ligament tissue specimens and associated clinical diagnoses in this study are shown in [Table I](#tI-ijmm-39-01-0135){ref-type="table"} and [Fig. 2](#f2-ijmm-39-01-0135){ref-type="fig"}. Single- and multiple-level TOLF and non-TOLF ligaments were aseptically obtained from patients during surgery and ligaments were obtained from non-ossified sites to avoid any possible contamination of osteogenic cells. This study was approved by the Ethics Committee of Peking University Third Hospital (Beijing, China) and all patients provided written informed consent prior to obtaining the samples.

Cell culture
------------

Cell culture was conducted as previously described ([@b21-ijmm-39-01-0135]). The ligament specimens were minced into 0.5-mm^3^ sections and digested with 0.25% trypsin (Gibco, Grand Island, NY, USA) for 1 h at 37°C followed by 200 U/ml type I collagenase (Sigma-Aldrich, St. Louis, MO, USA) for 4 h at 37°C. The sections were maintained in low glucose Dulbecco\'s Modified Eagle\'s Medium (Hyclone, Logan, UT, USA) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 *µ*g/ml streptomycin (all from Gibco) in a humidified incubator at 37°C and 5% CO~2~. Cells derived from explants were passaged by digestion with 0.25% trypsin. Passage 3 cells were used for the experiments. The morphology of the primary cells was observed visually under a microscope (5221227/293232; Leica, Wetzlar, Germany) and images were obtained under the magnification of ×50, ×100 and ×200.

Application of mechanical stretch
---------------------------------

The cells were trypsinized and placed on a silicon chamber coated with type I collagen (Flexcell International, Hillsborough, NC, USA) at a density of 10,000 cells/cm^2^ and after 3 days, the cells reached confluence. Firstly, the cells derived from 6 patients (TOLF and non-TOLF patients) and were subjected to cyclic mechanical stretch at 0, 5, 10, 15 and 20% by using a equi-biaxial cell-stretching apparatus (Flexcell FX-4000 Tension Plus System; Flexcell International) at 0.5 Hz and 37°C in a humidified atmosphere of 95% air and 5% CO~2~ for 12 and 24 h, and the optimal magnitude of stretch was determined according to the result. The optimal magnitude of stretch was then applied to cells from all the patients for 6, 12 and 24 h.

ALP activity assay
------------------

ALP activity was quantitatively analyzed using the LabAssay ALP kit (Wako, Osaka, Japan) and by staining using a commercial kit (Genmed, Shanghai, China). For the quantitative assay, total cellular protein was isolated from the cultured cells using radioimmunoprecipitation (RIPA) extraction buffer (Applygen Technologies, Beijing, China) and the concentration was determined using the bicinchoninic acid (BCA) method. The extracted protein solution was analyzed for ALP activity according to the manufacturer\'s instructions, with the activity reported relative to the protein concentration (U/mg). The cells were stained for ALP activity and ALP-positive cells were blue, while the counterstained nuclei appeared red. Micrographs of 10 random fields were obtained for analysis. Stained areas were measured using Image-Pro Plus 6.0 software (Media Cybernetics, Rockville, MD, USA), and the ratio of stained cells to the number of total cells was determined.

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
----------------------------------------------------------------------

Total RNA was extracted from the cell monolayers using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA), and 1 *µ*g total RNA was reverse transcribed into cDNA using the GoScript Reverse Transcription System (Promega Corp., Madison, WI, USA). The primers used for amplification are listed in [Table II](#tII-ijmm-39-01-0135){ref-type="table"}. qPCR was performed in triplicate using SYBR-Green SuperReal PreMix Plus \[Tiangen Biotech (Beijing) Co., Ltd., Beijing, China\] and the iQ5 PCR system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The reaction conditions were as follows: 95°C for 10 min, and 40 cycles of 95°C for 15 sec and 60°C for 1 min. Data are represented as cycle threshold (Ct) values. The RNA levels in different samples were compared using the 2^−ΔΔCt^ method and were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels.

Western blot analysis
---------------------

Total cellular protein was isolated from the cultured cells using RIPA extraction buffer and the concentration was determined by BCA assay. A total of 30 *µ*g protein per well was separated by 10--15% SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes, which were blocked for 2 h at 24--25°C with 5% BSA/TBST and then incubated overnight at 4°C with the following primary antibodies: rabbit monoclonal anti-BMP2 (1:1,000; ab183729), mouse monoclonal anti-osterix (1:1,000; ab57335), rabbit polyclonal anti-OPN (1:1,000; ab181440) and rabbit monoclonal anti-ALP (1:1,000; ab186422) (all from Abcam, Cambridge, UK); and mouse monoclonal anti-GAPDH (1:2,000; BE0023; Bioeasytech, Beijing, China). Immunoreactivity was detected with IRDye 800cw-conjugated goat anti-rabbit/-mouse IgG (1:10,000; LI-COR Biosciences, Lincoln, NE, USA) secondary antibodies and visualized with an Odyssey infrared imaging system (LI-COR Biosciences), with gray values analyzed using Odyssey v3.0 software.

Statistical analysis
--------------------

In this study, the data are presented as the means ± standard deviation and were analyzed using SPSS 20.0 software (SPSS, Inc., Chicago, IL, USA). The mRNA expression data were evaluated by one-way analysis of variance (ANOVA) with a post hoc Dunnett\'s test (compared to 0 h in the non-TOLF group) and the post hoc Tukey\'s test for multiple comparisons. Other data sets were evaluated by ANOVA with a post hoc Tukey\'s test for multiple comparisons. A value of P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

Morphology of primary cells and determination of the optimal mechanical stress level
------------------------------------------------------------------------------------

The primary cells in all 3 groups were long and spindle-shaped and exhibited fibrocyte-like adherent growth ([Fig. 3A](#f3-ijmm-39-01-0135){ref-type="fig"}). Following exposure to different levels (0, 5, 10, 15 and 20%) of cyclic mechanical stress for 12 or 24 h, osteogenic potency was evaluated with the ALP activity assay. In the non-TOLF group, ALP activity remained constant at different levels of cyclic mechanical stress and periods of induction ([Fig. 3B and C](#f3-ijmm-39-01-0135){ref-type="fig"}). However, ALP activity was increased in the TOLF group, particularly upon the application of 15% mechanical stress for 12 h ([Fig. 3B](#f3-ijmm-39-01-0135){ref-type="fig"}) and 24 h ([Fig. 3C](#f3-ijmm-39-01-0135){ref-type="fig"}). We therefore applied a mechanical stress of 15% for the subsequent experiments.

Changes in ALP activity induced by cyclic mechanical stress
-----------------------------------------------------------

In the absence of cyclic mechanical stress, ALP activity was higher in the multiple-level than in the single-level TOLF and non-TOLF groups (P\<0.001). The activity was slightly higher in the single-level TOLF than in the non-TOLF group, although the difference was not statistically significant. At longer induction times, ALP activity increased in the 2 TOLF groups, with a greater increase observed in the multiple-level group ([Fig. 4A](#f4-ijmm-39-01-0135){ref-type="fig"}).

There were almost no ALP-positive cells in the non-TOLF group regardless of stress application. However, there were many ALP-positive cells in the 2 TOLF groups even in the absence of stress, and their numbers increased with the application time, particularly in the multiple-level TOLF group ([Fig. 4B--D](#f4-ijmm-39-01-0135){ref-type="fig"}). The semi-quantitative analysis of the stained area and positive cells yielded similar results ([Fig. 4E and F](#f4-ijmm-39-01-0135){ref-type="fig"}).

Osteogenesis marker expression is upregulated at the mRNA level by cyclic mechanical stress
-------------------------------------------------------------------------------------------

The mRNA levels of osteogenesis markers, including ALP, BMP2, osterix, Runx2, OCN and OPN were upregulated by cyclic mechanical stress in the single- and multiple-level TOLF groups, as determined by RT-qPCR. ALP expression was highest in the multiple-level TOLF group, followed by the single-level and non-TOLF groups at 0 h, and it increased over time in both TOLF groups with the application of stress; at 24 h, the ALP expression level was 2.1-fold higher in the multiple-level group than in the single-level group ([Fig. 5A](#f5-ijmm-39-01-0135){ref-type="fig"}). Similar trends were observed for BMP2; at 24 h, the expression level was 2.3-fold higher in the multiple-level group than in the single-level group ([Fig. 5B](#f5-ijmm-39-01-0135){ref-type="fig"}). The mRNA expression of osterix was highest in the multiple-level TOLF group at 0 h, followed by the single-level and non-TOLF groups, although the differences between the groups were not statistically significant. While the application of mechanical stress did not affect the single-level group, the expression level increased in the multiple-level TOLF group relative to the other 2 groups at 12 h, and was approximately 2.1-fold higher than that in the single-level TOLF group at 24 h ([Fig. 5C](#f5-ijmm-39-01-0135){ref-type="fig"}). In addition, Runx2 expression was higher in the TOLF groups than in the non-TOLF group and it increased with stress application; at 0 and 24 h, the Runx2 transcript level was higher in the multiple-level group than in the single-level group ([Fig. 5D](#f5-ijmm-39-01-0135){ref-type="fig"}). Likewise, OCN and OPN expression was higher in the TOLF groups than in the non-TOLF group ([Fig. 5E and F](#f5-ijmm-39-01-0135){ref-type="fig"}), and it was increased by stress in the multiple-level TOLF group; OCN expression was 1.8-fold higher in the multiple-level group than in the single-level group at 24 h.

Pairwise comparisons among the 3 groups indicated that the expression of ALP, BMP2, osterix and OPN was higher in the multiple-level TOLF group than in the other 2 groups. OCN expression was higher in the multiple-level TOLF group than in the non-TOLF group, whereas there were no differences in Runx2 expression among the 3 groups. Moreover, the expression levels of all markers were similar between single-level and non-TOLF groups ([Table III](#tIII-ijmm-39-01-0135){ref-type="table"}).

Osteogenic marker expression is upregulated at the protein level by cyclic mechanical stress
--------------------------------------------------------------------------------------------

The protein levels of osteogenic markers were assessed by western blot analysis ([Fig. 6A](#f6-ijmm-39-01-0135){ref-type="fig"}). ALP and osterix were more highly expressed in the multiple-level TOLF group than in the other 2 groups, and their expression increased with the application of mechanical stress to levels that were significantly higher at 12 h ([Fig. 6B and C](#f6-ijmm-39-01-0135){ref-type="fig"}). The expression of both markers was higher in the single-level TOLF group than in the non-TOLF group. The BMP2 and OPN levels were higher in the TOLF groups than in the non-TOLF group. However, their levels in the single-level TOLF group were not altered with stress application ([Fig. 6D and E](#f6-ijmm-39-01-0135){ref-type="fig"}).

Discussion
==========

Many studies have demonstrated the critical role of mechanical stress in the development of TOLF ([@b7-ijmm-39-01-0135],[@b15-ijmm-39-01-0135],[@b22-ijmm-39-01-0135]--[@b25-ijmm-39-01-0135]). We previously reported that mechanical stress induced the osteogenic differentiation of ligament cells derived from patients with TOLF, which in turn promoted OLF, leading us to conclude that stress facilitated, but did not initiate the development of TOLF ([@b10-ijmm-39-01-0135]). In the present study, we used cyclic stress to induce osteogenesis in fibroblasts derived from non-TOLF and single and multiple-level TOLF in order to assess genetic differences in the osteogenic differentiation potency.

Although the morphology of ligament cells derived from the 3 groups was similar, the cells differed in terms of osteogenic potency, possibly due to cytogenetic differences. Ligament cells from patients with TOLF already possess certain osteoblast characteristics, including the upregulation of specific markers, whereas cells from non-TOLF patients exhibit a fibroblast phenotype ([@b3-ijmm-39-01-0135],[@b26-ijmm-39-01-0135]--[@b28-ijmm-39-01-0135]). OCN and collagen type II are expressed in cells derived from patients with OLF, but not cells derived from non-OLF patients; cells derived from patients with OLF would thus present an osteoblast and chondrocyte phenotype ([@b29-ijmm-39-01-0135]). Another study reported that stress induced the mineralization of cells from patients with TOLF ([@b10-ijmm-39-01-0135]). These results demonstrate that cells from patients with TOLF have a greater potential for differentiation from fibroblasts to osteoblasts or chondrocytes.

Clinically, OLF mainly occurs in the thoracic spine, but rarely in the cervical and lumbar vertebrae that have a greater range of motion, which possibly indicates that ligament cells from patients with TOLF are sensitive to a certain range of cyclic mechanical stress in osteogenic induction. In addition, the degree of mechanical stress required for osteogenic induction has been investigated in several studies ([@b30-ijmm-39-01-0135]--[@b32-ijmm-39-01-0135]). For example, an equi-biaxial stretch chamber applying 9% mechanical stress was determined as optimal for inducing the differentiation of cells from patients with TOLF ([@b10-ijmm-39-01-0135]). On the other hand, 20% stress has been applied to cells from patients with TOLF and OPLL using the Flexcell FX-3000 and -4000 systems, respectively, although these studies did not explore the optimal range of mechanical stress ([@b15-ijmm-39-01-0135],[@b33-ijmm-39-01-0135]). The differences between these devices, as well as the reactivity of cells derived from different tissues underscored the importance of exploring the optimal level of mechanical stress in the present study. ALP is a sensitive and specific indicator of the early stage of osteoblast differentiation ([@b34-ijmm-39-01-0135]); we found that 15% stress produced the highest ALP activity, indicating that this strength effectively induced osteogenesis of ligament cells from patients with TOLF. We also found that ALP activity was higher in the 2 TOLF groups than in the non-TOLF group, with the highest activity observed in the multiple-level group. Accordingly, a larger area of positive ALP staining, corresponding to a higher osteogenic potency, was observed in this group as compared to the single-level TOLF group.

BMP2 is an osteogenic factor that has been implicated in the ossification of the spinal ligament. BMP and its receptors have been found to be widely expressed in OLF tissues, but to be only partially expressed in the region connecting the ligamentum flavum and vertebrae in non-OLF tissues ([@b35-ijmm-39-01-0135]), leading these investigators to conclude that the aberrant expression of BMP and its receptors contributes to OLF. Similarly, another study reported an abundance of BMP2-positive fibroblasts distributed in areas of calcification and ossification in TOLF ([@b14-ijmm-39-01-0135]). In this study, we found that the BMP2 mRNA level was higher in the multiple-level group than in the single-level and non-TOLF groups at 0 h and that it increased with application of cyclic mechanical stress. These results demonstrate that BMP2 plays an important role in the osteogenic differentiation of cells from patients with TOLF and that differences in expression may account for the distinct prognoses of single- and multiple-level TOLF.

Runx2 is a transcription factor that regulates osteoblast differentiation. In a previous study, Runx2 expression was found to be higher in OLF than in the control and was mainly expressed in hyperplastic and hypertrophic cartilage cells ([@b7-ijmm-39-01-0135]). In another study, cyclic tensile strain applied for 24 h increased Runx2 and OPN mRNA levels in cells from OLF sections, whereas similar mechanical stress had negligible effects on cells from non-OLF sections ([@b15-ijmm-39-01-0135]). In the present study, Runx2 expression was similar in the multiple- and single-level TOLF, and higher than that in the non-TOLF group, indicating that Runx2 expression cannot be used as a marker for distinguishing the osteogenic potency of single- and multiple-level TOLF.

Osterix is a transcription factor activated upon mechanical stress that regulates the transcription of osteogenesis-related genes. Our previous study showed that mechanical stress induced osterix and Runx2 overexpression in TOLF cells ([@b10-ijmm-39-01-0135]). It has also been reported that osterix is more highly expressed in OLF- than in non-OLF-derived cells and is mainly distributed in cartilage cells located in the calcified cartilage and fibrocartilage layers ([@b7-ijmm-39-01-0135]). Osterix has been shown to promote osteoblast differentiation and mineralization at a heterotopic site ([@b36-ijmm-39-01-0135]). In this study, osterix expression was higher in the multiple-level group as compared to the single-level TOLF group at 0 h and increased with the application of mechanical stress in the former, but not in the latter group, suggesting that osterix can serve as a marker for multiple-level TOLF.

OCN is an extracellular matrix protein that reflects the status of the process of osteogenesis ([@b37-ijmm-39-01-0135]). OPN is secreted as an adhesive glycophosphoprotein and modulates matrix mineralization in mechano-transduction ([@b38-ijmm-39-01-0135]). Previous studies have reported that OCN and OPN expression increase with the application of mechanical stress. This was confirmed by the results presented in this study: at an early stage of mechanical stress, the OCN and OPN levels were comparable in the 2 TOLF groups; however, over time, the levels were upregulated to a greater degree in the multiple-level than in the singe-level group. This indicates that the osteogenic differentiation of multiple-level TOLF-derived cells is more active under the application of cyclic mechanical stress.

Clinically, multiple-level TOLF differs from single-level lesions in terms of disease progression and clinical outcomes, and multiple-level TOLF has a poor prognosis and may continue to develop after surgical resection ([@b12-ijmm-39-01-0135],[@b39-ijmm-39-01-0135],[@b40-ijmm-39-01-0135]), suggesting that the osteogenic potency may be differ between them, which is consistent with our experimental results. There were some limitations to this study. Firstly, the mechanistic basis for differences in osteogenic potency between multiple- and single-level TOLF requires more detailed investigation, such as bioinformatics analysis of gene expression profiles, and we aim to do this in future studies. In addition, in the current study, we examined changes in osteogenic potency and gene expression in cells from patients with TOLF in response to mechanical stress *in vitro*, and did not consider other types of stress that are present *in vivo*, including compression, twisting and shear forces. Therefore, additional studies using an *in vivo* TOLF model are required.

In conclusion, this study demonstrated that ligament cells from patients with TOLF were sensitive to a certain range of mechanical stress in osteogenic differentiation. Single- and multiple-level TOLF differed in terms of osteogenic potency and related gene expression under cyclic stress, with the latter exhibiting a greater potency for osteogenic differentiation that may be related to the different pathogenesis of them and contribute to the different clinical outcome.
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![Thoracic ossification of ligament flavum classification based on the lesion distribution as determined by magnetic resonance imaging.](IJMM-39-01-0135-g00){#f1-ijmm-39-01-0135}

![MRI image of patients in the non-thoracic ossification of ligament flavum (TOLF) and single- and multiple-level TOLF groups. N, non-TOLF; S, single-level TOLF; M, multiple-level TOLF; MRI, magnetic resonance imaging. The numbers 1--8 indicate the sample no.](IJMM-39-01-0135-g01){#f2-ijmm-39-01-0135}

![Morphology of primary ligament cells and quantitative analysis of alkaline phosphatase (ALP) activity in determination of optimal stress level. Morphology of primary ligament cells. (A) Cell morphoology in the cells from patients in the different groups: panel 1, non-TOLF gorup; panel 2, single-level TOLF group; and panel 3, multiple-level TOLF goup (×100 magnification). TE, tissue explant. (B and C) Quantitative analysis of ALP activity in TOLF and non-TOLF groups under different strengths of cyclic mechanical stress (0, 5, 10, 15 and 20%) for (B) 12 h and (C) 24 h (data are the means ± standard deviation; n=3 patients/group). ^\*^P\<0.05, ^\*\*^P\<0.01, ^\*\*\*^P\<0.001 vs. 0% in each group. TOLF, thoracic ossification of ligament flavum.](IJMM-39-01-0135-g02){#f3-ijmm-39-01-0135}

![Change in alkaline phosphatase (ALP) activity induced by cyclic mechanical stress. (A) Quantitative analysis of ALP activity in non-thoracic ossification of ligament flavum (TOLF) and single- and multiple-level TOLF (data are the means ± standard deviation; n=6 patients/group). ^\*^P\<0.05, ^\*\*\*^P\<0.001 vs. non-TOLF at the same time point. ^\#\#\#^P\<0.001 vs. single-level TOLF at the same time point. (B and D) Images of ALP activity staining: (B) gross observation, (C) light microscopy, and (D) with nuclear counterstaining (×40 magnification for panels C; and ×100 magnification for panels D). (E and F) Semi-quantitative analysis of the area of (E) ALP staining and (F) stained cells (data are the means ± standard deviation; n=10 micrographs/group). ^\*\*^P\<0.01, ^\*\*\*^P\<0.001 vs. non-TOLF at the same time point. ^\#\#^P\<0.001, ^\#\#\#^P\<0.001 vs. single-level TOLF at the same time point.](IJMM-39-01-0135-g03){#f4-ijmm-39-01-0135}

![Osteogenic marker expression at the mRNA level. Analysis of mRNA expression levels in cells from patients with non-thoracic ossification of ligament flavum (TOLF) and single- and multiple-level TOLF by RT-qPCR. (A) ALP, (B) bone morphogenetic protein-2 (BMP2), (C) osterix, (D) Runt-related transcription factor-2 (Runx-2), (E) osteocalcin (OCN) and (F) osteopontin (OPN) (data are the means ± standard deviation; n=8 patients/group). ^\*^P\<0.05, ^\*\*^P\<0.01, ^\*\*\*^P\<0.001 vs. 0 h in non-TOLF group.](IJMM-39-01-0135-g04){#f5-ijmm-39-01-0135}

![Osteogenic marker expression at the protein level. (A) Western blot analysis of thoracic ossification of ligament flavum (TOLF) and non-TOLF samples. (B and E) Semi-quantitative analysis of protein expression in non-TOLF and single- and multiple-level TOLF. (B) Alkaline phosphatase (ALP), (C) osterix, (D) bone morphogenetic protein-2 (BMP2), and (E) osteopontin (OPN) (mean ± standard deviation; n=3 patients/group). ^\*^P\<0.05, ^\*\*^P\<0.01, ^\*\*\*^P\<0.001 vs. non-TOLF at the same time point. ^\#^P\<0.05, ^\#\#^P\<0.01 vs. single-level TOLF at the same time point.](IJMM-39-01-0135-g05){#f6-ijmm-39-01-0135}

###### 

Patient information.

  Groups                Sample no.                                                                                                         
  --------------------- -------------------- ------------------- ------------ -------------- --------------- -------------- -------------- ---------------
  Non-TOLF                                                                                                                                 
   Age/gender           62/M                 44/F                58/M         52/M           44/M            42/M           52/M           43/F
   Diagnosis            T11-12 TDH           T8,10,12 fracture   T11-12 TDH   T12 fracture   T7-9 fracture   T12-L1 TDH     T12 fracture   T6-7 fracture
  Single-level TOLF                                                                                                                        
   Age/gender           54/M                 44/F                65/F         63/M           69/F            58/M           43/F           70/M
   Ossification level   T10-11               T10-11              T10-11       T11-12         T10-11          T10-11         T11-12         T10-11
  Multiple-level TOLF                                                                                                                      
   Age/gender           57/F                 59/F                61/M         68/M           55/M            59/F           52/F           58/F
   Classification       Intermittent         Intermittent        Continuous   Continuous     Intermittent    Intermittent   Intermittent   Intermittent
   Ossification level   T2-4, T5-7, T10-11   T1-3,T8-11          T1-8         T2-8           T2-5, T9-12     T2-5,T8-11     T2-6,T9-L1     T2-3,6-7,8-12

Age is presented in year. TOLF, thoracic ossification of ligament flavum; TDH, thoracic disc herniation; M, male; F, female.

###### 

Primers used for RT-qPCR.

  -------------------------------------------------------------------------------------------------
  Gene      Primer sequence                        Product size (bp)   Annealing temperature (°C)
  --------- -------------------------------------- ------------------- ----------------------------
  GAPDH     Forward: 5′-CAGGAGGCATTGCTGATGAT-3′\   126                 60
            Reverse: 5′-GAAGGCTGGGGCTCATTT-3′                          

  ALP       Forward: 5′-AAGGACGCTGGGAAATCTGT-3′\   117                 57
            Reverse: 5′-GGGCATCTCGTTGTCTGAGT-3′                        

  BMP2      Forward: 5′-TCAAGCCAAACACAAACAGC-3′\   105                 55
            Reverse: 5′-GGAGCCACAATCCAGTCATT-3′                        

  Osterix   Forward: 5′-GAGGTTCACTCGTTCGGATG-3′\   120                 56
            Reverse: 5′-TGGTGTTTGCTCAGGTGGT-3′                         

  Runx2     Forward: 5′-CCGTCCATCCACTCTACCAC-3′\   139                 56
            Reverse: 5′-ATGAAATGCTTGGGAACTGC-3′                        

  OCN       Forward: 5′-CTCACACTCCTCGCCCTATT-3′\   143                 58
            Reverse: 5′-CGCCTGGGTCTCTTCACTAC-3′                        

  OPN       Forward: 5′-GCCGTGGGAAGGACAGTTAT-3′\   114                 56
            Reverse: 5′-GCTCATTGCTCTCATCATTGG-3′                       
  -------------------------------------------------------------------------------------------------

ALP, alkaline phosphatase; BMP2, bone morphogenetic protein-2; Runx-2, Runt-related transcription factor-2; OPN, osteopontin; OCN, osteocalcin.

###### 

Variance analysis of different curves using ANOVA with Tukey\'s post-hoc test.

  Gene      Non-TOLF vs. single-level TOLF groups   Non-TOLF vs. multiple-level TOLF groups   Single-level TOLF vs. multiple-level TOLF groups
  --------- --------------------------------------- ----------------------------------------- --------------------------------------------------
  ALP       ns                                      P\<0.001                                  P\<0.01
  BMP-2     ns                                      P\<0.001                                  P\<0.001
  Osterix   ns                                      P\<0.01                                   P\<0.01
  Runx2     ns                                      ns                                        ns
  OCN       ns                                      P\<0.05                                   ns
  OPN       ns                                      P\<0.001                                  P\<0.05

ns, not significant; ALP, alkaline phosphatase; BMP2, bone morphogenetic protein-2; Runx-2, Runt-related transcription factor-2; OCN, osteocalcin; OPN, osteopontin.
